In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fondazione San Raffaele del Monte Tabor

www.sanraffaele.org

Latest From Fondazione San Raffaele del Monte Tabor

Commercial Considerations For Cell And Gene Therapies: Viewpoints From The 2016 ARM Meeting

There are still many lessons to be learned in commercializing cell and gene therapies. Experts in the industry discussed challenges and best practices at the Alliance for Regenerative Medicine's annual meeting in October.

BioPharmaceutical Commercial

Was Enobia’s Sale A High Water Mark For Rare Disease Deals?

Alexion’s “hotly contested” purchase of Enobia last December didn’t get much attention, but it marked a watershed year for rare disease drug deals. Will high drug prices, skittish regulators and a gold-rush push by Big Pharma start to sour the sector?

BioPharmaceutical United States

Recent Tech Transfer Deals (11/10)

Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register